<DOC>
	<DOCNO>NCT00744523</DOCNO>
	<brief_summary>The objective ARMOUR study evaluate safety effectiveness Mo.Ma proximal flow blockage cerebral protection device patient high surgical risk carotid endarterectomy undergo carotid artery stenting</brief_summary>
	<brief_title>Proximal Protection With The Mo.Ma Device During Carotid Stenting</brief_title>
	<detailed_description>Test Device : Mo.Ma™ Proximal Flow Blockage Cerebral Protection Device . Single size catheter device 9 French introducer sheath compatible shaft ( out diameter ) 6 French compatible work channel ( inner diameter ) , integrate two compliant balloon intend achieve endovascular clamp external carotid artery ( ECA ) 3-6 mm diameter common carotid artery ( CCA ) 5-13 mm diameter . Primary Objective : Evaluate safety effectiveness Mo.Ma device cerebral protection treatment internal carotid artery ( ICA ) stenoses , may may involve bifurcation CCA , subject consider high surgical risk complication carotid endarterectomy ( CEA ) . Primary Endpoint : Major adverse cardiac cerebrovascular event ( MACCE ) within 30 day implantation . MACCE define : myocardial infarction ( MI ) , stroke , death day 30 post-procedure .</detailed_description>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>General inclusion criterion Subject meet one high surgical risk criterion . Subject ≥ 18 year old . Subject candidate single lesion carotid artery stenting use femoral arterial approach . Subject willing able comply followup evaluation specify time . Subject ( legal representative ) understand nature procedure provide informed consent , prior enrollment study . If female subject , currently pregnant state intention become pregnant study . Angiographic inclusion criterion ( determine ≤ 30 day prior procedure ) : Target lesion stenosis ( % stenosis = ( 1N/D ) X 100 ) 1 , document selective angiography preintervention , ≥ 80 % stenosis asymptomatic subject ≥ 50 % stenosis symptomatic subject . Symptomatic define carotid stenosis associate ipsilateral transient visual TIA evidence byamaurosis fugax , ipsilateral hemispheric TIAs ipsilateral ischemic stroke within 6 month prior enrollment . Target lesion within internal carotid artery and/or involve bifurcation CCA . External carotid artery diameter Mo.Ma device position 36 mm . Common carotid artery diameter Mo.Ma device position 513 mm . General exclusion criterion Subject participate , participate , plan participate another clinical study may affect either preprocedure followup result . Subject chronic paroxysmal atrial fibrillation treat Coumadin . Subject undergone prior stenting ipsilateral carotid artery . Subject 's life expectancy less twelve month . Subject unable respond external question stimuli exert pressure contralateral hand . Subject suffer dementia . Subject document intolerance BOTH heparin Angiomax . Subject allergy contraindication acetylsalicylic acid ( ASA ) . Subject document allergy device material . Subject document allergy radiographic contrast pretreated . Subject document allergy contraindication BOTH clopidogrel ticlopidine . Subject active bleeding diathesis require blood transfusion within one ( 1 ) month prior index procedure . Subject MI within 72 hour prior carotid stenting . Subject coronary artery bypass graft ( CABG ) vascular surgery within 30 day PRIOR TO index procedure ( percutaneous coronary intervention permissible provide cardiac enzyme normal within 24 hour index procedure ) , OR plan CABG , vascular surgery , percutaneous coronary intervention ( PCI ) , invasive medical procedure plan within 30 day AFTER index procedure . ( Unplanned urgent emergent procedure may perform anytime clinically indicate ) . Subject major residual neurological deficit ( stroke scale : Barthel ≤ 60 , NIH ≥ 15 Rankin &gt; 3 ) preprocedure neurological exam . Subject transient ischemic attack ( TIA ) amaurosis fugax within 48 hour prior index procedure . Subject stroke retinal artery occlusion within one ( 1 ) month prior index procedure . Subject abnormal preintervention blood count platelets &lt; 50,000/cubic mm &gt; 700,000/cubic mm white blood cell count &lt; 3,000/cubic mm . Subject severe chronic renal failure ( creatinine &gt; 2.5 mg/dl ) . Subject currently treat cerebral carcinoma sarcoma . Subject peripheral vascular disease , preclude safe femoral artery sheath insertion . Subject unable unwilling undergo insertion temporary pacemaker . Angiographic exclusion criterion ( determine ≤ 30 day prior procedure ) : The target carotid artery completely occlude . The common carotid artery ostium stenosis require treatment . Multiple carotid stenosis exist internal carotid artery ( ICA ) cover one stent . The presence ipsilateral intracranial stenosis require treatment . The presence intracranial tumor ( ) , arteriovenous malformation ( ) ( AVMs ) , aneurysm ( ) require treatment . The inability position stiff .035 '' guidewire external carotid artery ( ECA ) . Contralateral occlusion internal carotid artery vertebral artery . Aortic arch anatomical anomaly preclude safe placement device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>carotid artery stenting</keyword>
	<keyword>stroke</keyword>
	<keyword>cerebral protection</keyword>
	<keyword>high surgical risk</keyword>
</DOC>